These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3841303)

  • 21. Overcoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability.
    Zasadzinski JA; Stenger PC; Shieh I; Dhar P
    Biochim Biophys Acta; 2010 Apr; 1798(4):801-28. PubMed ID: 20026298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonic and jet aerosolization of phospholipids and the effects on surface activity.
    Marks LB; Notter RH; Oberdorster G; McBride JT
    Pediatr Res; 1983 Sep; 17(9):742-7. PubMed ID: 6622110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.
    Cockshutt AM; Weitz J; Possmayer F
    Biochemistry; 1990 Sep; 29(36):8424-9. PubMed ID: 2252903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of albumin and erythrocyte membranes on spread monolayers of lung surfactant lipids.
    Rachana R; Banerjee R
    Colloids Surf B Biointerfaces; 2006 Jun; 50(1):9-17. PubMed ID: 16650737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of surfactant-associated protein-A (SP-A) on the activity of lipid extract surfactant.
    Chung J; Yu SH; Whitsett JA; Harding PG; Possmayer F
    Biochim Biophys Acta; 1989 Apr; 1002(3):348-58. PubMed ID: 2713385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of surfactant activity by Pneumocystis carinii organisms and components in vitro.
    Wang Z; Foye A; Chang Y; Chess PR; Wright TW; Bhagwat S; Gigliotti F; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1124-31. PubMed ID: 15886399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro inhibition of biophysical surface properties and change in ultrastructures of exogenous pulmonary surfactant by albumin or fibrinogen.
    Park J; Bae CW; Choi YM
    J Korean Med Sci; 1998 Apr; 13(2):123-30. PubMed ID: 9610611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships among surfactant fraction lipids, proteins and biophysical properties in the developing rat lung.
    Farrell PM; Bourbon JR; Notter RH; Marin L; Nogee LM; Whitsett JA
    Biochim Biophys Acta; 1990 May; 1044(1):84-90. PubMed ID: 2340311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic surface activity of a fully synthetic phospholipase-resistant lipid/peptide lung surfactant.
    Walther FJ; Waring AJ; Hernandez-Juviel JM; Gordon LM; Schwan AL; Jung CL; Chang Y; Wang Z; Notter RH
    PLoS One; 2007 Oct; 2(10):e1039. PubMed ID: 17940603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface properties of sulfur- and ether-linked phosphonolipids with and without purified hydrophobic lung surfactant proteins.
    Chang Y; Wang Z; Schwan AL; Wang Z; Holm BA; Baatz JE; Notter RH
    Chem Phys Lipids; 2005 Oct; 137(1-2):77-93. PubMed ID: 16109391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.
    Wang Z; Chang Y; Schwan AL; Notter RH
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A spreading technique for forming film in a captive bubble.
    Putz G; Walch M; Van Eijk M; Haagsman HP
    Biophys J; 1998 Nov; 75(5):2229-39. PubMed ID: 9788918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adsorption, compression and stability of surface films from natural, lipid extract and reconstituted pulmonary surfactants.
    Yu SH; Possmayer F
    Biochim Biophys Acta; 1993 Apr; 1167(3):264-71. PubMed ID: 8481387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a surfactant-associated protein and calcium ions on the structure and surface activity of lung surfactant lipids.
    Hawgood S; Benson BJ; Hamilton RL
    Biochemistry; 1985 Jan; 24(1):184-90. PubMed ID: 3922400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity.
    Holm BA; Enhorning G; Notter RH
    Chem Phys Lipids; 1988 Nov; 49(1-2):49-55. PubMed ID: 3233711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pivotal role of anionic phospholipids in determining dynamic behavior of lung surfactant.
    Ingenito EP; Mora R; Mark L
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):831-8. PubMed ID: 10712330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A.
    Venkitaraman AR; Hall SB; Whitsett JA; Notter RH
    Chem Phys Lipids; 1990 Dec; 56(2-3):185-94. PubMed ID: 2095991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of surfactant dysfunction in early acute lung injury.
    Kennedy M; Phelps D; Ingenito E
    Exp Lung Res; 1997; 23(3):171-89. PubMed ID: 9184787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of pulmonary surfactant by oleic acid: mechanisms and characteristics.
    Hall SB; Lu RZ; Venkitaraman AR; Hyde RW; Notter RH
    J Appl Physiol (1985); 1992 May; 72(5):1708-16. PubMed ID: 1601776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A coagulative type of pulmonary surfactant depletion--a mechanism of damage to the pulmonary surfactant system].
    Koga Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):434-44. PubMed ID: 7927172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.